Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
BMC Infect Dis ; 24(1): 472, 2024 May 06.
Artículo en Inglés | MEDLINE | ID: mdl-38711008

RESUMEN

BACKGROUND: Sepsis is a common syndrome of multiorgan system dysfunction secondary to the dysregulated inflammatory response to infection. The role of pancreatic stone protein (PSP) in diagnosing sepsis has been investigated in previous studies. The meta-analysis aimed to comprehensively investigate the diagnostic value of PSP in identifying sepsis. METHODS: PubMed, Web of Science, Embase, Cochrane Library, and China National Knowledge Infrastructure (CNKI), were systematically searched. Studies investigating the diagnostic performance of PSP were included. Pooled sensitivity, specificity, positive Likelihood Ratio (+ LR) and negative Likelihood Ratio (-LR), diagnostic odds ratio (DOR), and area under the curve (AUC) of summary receiver operating characteristic (SROC) were calculated. RESULTS: The sensitivity of PSP was 0.88 (95% CI: 0.77-0.94), and the pooled specificity was 0.78 (95% CI: 0.65-0.87). Pooled + LR, -LR, and DOR were 4.1 (2.3, 7.3), 0.16 (0.07, 0.34), and 26 (7, 98). The AUC value for the SROC of PSP was 0.90 (0.87, 0.92). The pooled sensitivity, specificity, + LR and - LR, and DOR for PSP among neonates were 0.91 (95% CI: 0.84, 0.96), 0.66 (95% CI: 0.58, 0.74), 3.97 (95% CI: 0.53, 29.58), 0.13 (95% CI: 0.02, 1.00), and 31.27 (95% CI: 0.97, 1004.60). CONCLUSIONS: This study indicates that PSP demonstrated favorable diagnostic accuracy in detecting sepsis. Well-designed studies are warranted to ascertain the value of PSP measurement to guide early empirical antibiotic treatment, particularly in neonates.


Asunto(s)
Biomarcadores , Litostatina , Sepsis , Humanos , Biomarcadores/sangre , Litostatina/sangre , Curva ROC , Sensibilidad y Especificidad , Sepsis/diagnóstico
2.
Chem Biodivers ; 20(7): e202300513, 2023 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-37329234

RESUMEN

Based on the use of quercetin for treating diabetes and H2 S for promoting wound healing, a series of three quercetin-linker-H2 S donor conjugates was designed, synthesized and characterized by 1 H-NMR, 13 C-NMR and MS. Meanwhile, in vitro evaluation of these compounds was also researched by IR-HepG2 treatment experiment, MTT assay, scratch test and tubule formation experiment. The three compounds could be used to treat insulin resistance induced by high glucose and promote the proliferation of human umbilical vein endothelial cells, wound healing, and the formation of tubules in vitro under a high-glucose environment. Our results illustrate that these compounds could be used to treat diabetes and promote wound healing at the same time. Furthermore, molecular docking study results of the compounds were consistent with the evaluated biological activity. In vivo research of compounds is underway.


Asunto(s)
Diabetes Mellitus , Quercetina , Humanos , Quercetina/farmacología , Simulación del Acoplamiento Molecular , Cicatrización de Heridas , Diabetes Mellitus/tratamiento farmacológico , Células Endoteliales de la Vena Umbilical Humana , Glucosa
3.
Chem Biodivers ; 19(10): e202200692, 2022 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-36082623

RESUMEN

In this work, a series of 7-azaindole analogs were designed by the bioisosteric principle based on the pharmacodynamic parent nucleus. Moreover, 5-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-N-{[6-(trifluoromethyl)pyridin-3-yl]methyl}pyrimidin-2-amine (compound P1) with the strongest interaction with colony-stimulating factor 1 receptor (CSF-1R) was screened by molecular docking. Compound P1 was successfully prepared by the six-step reaction with HPLC purity of 99.26 % and characterized by 1 H-NMR and ESI-MS spectra. In vitro bioactivity study showed that compound P1 appeared the cytotoxicity to MCF-7 and A549 cells, especially to HOS cells (IC50 =88.79±8.07 nM), while it had lower toxicity to normal L929 cells (IC50 =140.49±8.03 µM). In addition, compound P1 could induce HOS cell death by apoptosis and blocking the G0/G1 phase at nanomolar concentrations. The obtained results indicated that compound P1 might be a promising candidate compound for anticancer drug.


Asunto(s)
Antineoplásicos , Factor Estimulante de Colonias de Macrófagos , Simulación del Acoplamiento Molecular , Factor Estimulante de Colonias de Macrófagos/farmacología , Antineoplásicos/química , Aminas/farmacología , Relación Estructura-Actividad , Estructura Molecular , Ensayos de Selección de Medicamentos Antitumorales , Proliferación Celular , Línea Celular Tumoral
4.
J Biomater Sci Polym Ed ; 35(12): 1795-1818, 2024 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-38801735

RESUMEN

In this study, a novel drug delivery system (MSN-PEG-Hypericin) was successfully fabricated using tetraethyl orthosilicate and 3-aminopropyltriethoxysilane as raw materials, and the PEGylation of the prepared aminated mesoporous silica and grafting of hypericin onto the carrier were further conducted to obtain MSN-PEG-Hypericin. The successful preparation of MSN-PEG-Hypericin was characterized by several physical-chemical techniques. Furthermore, the MSN-PEG-Hypericin system increased the ability of hypericin to generate reactive oxygen species (ROS) in vitro. The cytotoxicity assay and hemolysis analysis showed that MSN-PEG-Hypericin had good biocompatibility. For antibacterial studies, the irradiation time and incubation time of photodynamic therapy (PDT) for S. aureus and E. coli were respectively 8 min and 8 h, and the concentrations of hypericin were 2.5 and 5 µg/mL. The result of triphenyl tetrazolium chloride assay indicated that MSN-PEG-Hypericin had stronger photodynamic antibacterial activity than free hypericin, and S. aureus was more sensitive to PDT than E. coli, which was related to their cell structural differences. The antibacterial mechanism study indicated that the generated ROS could destroy the bacterial structures and cause bacterial death due to the leakage of the contents. The MSN-PEG-Hypericin system prepared in this study had potential application prospects in the antibacterial field.


Asunto(s)
Antracenos , Antibacterianos , Disulfuros , Portadores de Fármacos , Escherichia coli , Perileno , Fotoquimioterapia , Polietilenglicoles , Especies Reactivas de Oxígeno , Dióxido de Silicio , Staphylococcus aureus , Perileno/análogos & derivados , Perileno/química , Perileno/farmacología , Antracenos/química , Polietilenglicoles/química , Antibacterianos/farmacología , Antibacterianos/química , Escherichia coli/efectos de los fármacos , Dióxido de Silicio/química , Staphylococcus aureus/efectos de los fármacos , Porosidad , Especies Reactivas de Oxígeno/metabolismo , Portadores de Fármacos/química , Disulfuros/química , Hemólisis/efectos de los fármacos , Humanos , Animales , Fármacos Fotosensibilizantes/farmacología , Fármacos Fotosensibilizantes/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA